prof. dr hab. Joanna Mika
Strona główna
/
Instytut
/
Pracownicy
/
prof. dr hab. Joanna Mika
prof. dr hab. Joanna Mika
Dokonania naukowe
- Publikacje
- Granty
Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model.
Autorzy:
DOI: 10.1016/j.neuropharm.2015.10.040
Date: 2016-03-01
Treatment with a carbon monoxide-releasing molecule (CORM-2) inhibits neuropathic pain and enhances opioid effectiveness in rats.
Autorzy:
DOI: 10.1016/j.pharep.2015.08.016
Date: 2016-02-01
Spontaneous cerebrospinal fluid leak at the clivus.
Autorzy:
DOI: 10.5114/wiitm.2015.55676
Date: 2016-01-01
Targeting the Microglial Signaling Pathways: New Insights in the Modulation of Neuropathic Pain.
Autorzy:
DOI: 10.2174/0929867323666160607120124
Date: 2016-01-01
Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Autorzy:
DOI: 10.1016/j.pnpbp.2015.07.005
Date: 2016-01-01
Anti-inflammatory properties of tianeptine on lipopolysaccharide-induced changes in microglial cells involve toll-like receptor-related pathways
Autorzy: Slusarczyk, J., Trojan, E., Glombik, K., Piotrowska, A., Budziszewska, B., Kubera, M., Popiolek-Barczyk, K., Lason, W., Mika, J., Basta-Kaim, A.
DOI: 10.1111/jnc.13452
Date: 2016-01-01
Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model
Autorzy: Agnieszka M. Jurga, Ewelina Rojewska, Anna Piotrowska, Wioletta Makuch, Dominika Pilat, Barbara Przewlocka, Joanna Mika
DOI: 10.1155/2016/5238730
Date: 2016-01-01
Dual Alleviation of Acute and Neuropathic Pain by Fused Opioid Agonist-Neurokinin 1 Antagonist Peptidomimetics.
Autorzy:
DOI: 10.1021/acsmedchemlett.5b00359
Date: 2015-12-01
IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model.
Autorzy:
DOI: 10.1016/j.ejphar.2015.05.058
Date: 2015-10-01
Effects of chronic doxepin and amitriptyline administration in naïve mice and in neuropathic pain mice model.
Autorzy:
DOI: 10.1016/j.neuroscience.2015.03.003
Date: 2015-05-01
Grant
OPUS 22 2021/43/B/NZ7/00230 Nowe strategie w farmakoterapii bólu neuropatycznego oparte na modulacji układu chemokin i jego wpływie na rozwój tolerancji opioidowej
15.07.2022 – 14.07.2026